Based on the published frequencies of the NOD2 variants in healthy individuals12, we estimate that carriers of the NOD2 minor alleles have at least a 2-fold increased risk of developing SC-CIP (OR = 2.19, 95% CI 1.16–2.95, p = 0.026). The gene discussed is NOD2; the disease is hereditary sensory and autonomic neuropathy.